NCT00310180 2026-03-18TAILORxNational Cancer Institute (NCI)Phase 3 Active not recruiting10,273 enrolled 14 charts
NCT02954874 2026-03-17Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNational Cancer Institute (NCI)Phase 3 Active not recruiting1,155 enrolled
NCT03598257 2026-03-17Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting300 enrolled
NCT00119262 2014-05-15Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerNational Cancer Institute (NCI)Phase 2 Completed226 enrolled 8 charts